BioNanomatrix, Inc., a Philadelphia developer of systems for biomedical research, molecular diagnostics and personalized medicine that are based on nanotechnology, today said it had received a $2 million follow-up grant from the National Institutes of Health.
Copyright PHILY - Philly.com
